Expert Consensus on Clinical Application of Implantable Biventricular Assist Devices
- PMID: 40643876
- DOI: 10.1007/s11596-025-00087-3
Expert Consensus on Clinical Application of Implantable Biventricular Assist Devices
Abstract
While biventricular assist devices (BiVADs) remain underutilized in Western countries for biventricular heart failure (BHF), their application is expanding in China. This consensus synthesizes international guidelines, medical evidence, and Chinese clinical expertise to establish standardized protocols for BiVAD management. Key recommendations include: (1) Preoperative right heart catheterization and echocardiography for central venous pressure (CVP): pulmonary capillary wedge pressure (PCWP) ratio and pulmonary artery pulsatility index (PAPi) assessment (Class I); (2) BiVAD indication in refractory BHF or high-risk right heart failure post-left ventricular assist device (LVAD) implantation (Class IIa); (3) Right atrial implantation as the preferred surgical approach (Class IIa); (4) Warfarin-based anticoagulation (INR 2.0-2.5) with aspirin, avoiding direct oral anticoagulants (DOACs) (Class III). The guidance addresses critical gaps in patient selection, pump speed titration, and complication management, positioning integrated BiVAD systems as a promising solution for complex BHF.
Keywords: Biventricular assist device; Double heart failure; End-stage heart failure; Heart failure management; Mechanical circulatory support.
© 2025. The Author(s), under exclusive licence to Huazhong University of Science and Technology.
Conflict of interest statement
Declarations. Competing interest: The authors declare that they have no conflicts of interest relevant to the content of this manuscript. Ethical Approval and Consent to Participate: Not applicable. Consent for Publication: Not applicable.
Similar articles
-
Implantation of integrated magnetically levitated biventricular assist devices (DuoCor) - a single center clinical experience.Int J Surg. 2025 Jul 25. doi: 10.1097/JS9.0000000000002879. Online ahead of print. Int J Surg. 2025. PMID: 40705518
-
Reoperation for the implantation of Corheart 6 biventricular assist devices due to severe right ventricular failure and aortic regurgitation following left ventricular assist device implantation.Int J Artif Organs. 2025 Aug;48(8):575-580. doi: 10.1177/03913988251351122. Epub 2025 Jul 23. Int J Artif Organs. 2025. PMID: 40696878
-
Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.Health Technol Assess. 2024 Aug;28(38):1-237. doi: 10.3310/MLFA4009. Health Technol Assess. 2024. PMID: 39189844 Free PMC article.
-
Percutaneous mechanical circulatory support for acute right heart failure: A practical approach.ESC Heart Fail. 2025 Aug;12(4):2652-2668. doi: 10.1002/ehf2.15305. Epub 2025 Apr 20. ESC Heart Fail. 2025. PMID: 40254772 Free PMC article. Review.
-
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. doi: 10.3310/hta9450. Health Technol Assess. 2005. PMID: 16303098
References
-
- Working Group on Heart Failure of National Center for Cardiovascular Quality Improvement. 2020 Clinical performance and quality measures for heart failure in China. Chin Circ J (Chinese). 2021;36(3):221–238.
-
- Khan MS, Shahid I, Bennis A, et al. Global epidemiology of heart failure. Nat Rev Cardiol. 2024;21(10):717–734. - PubMed
-
- Rajapreyar I, Solliman O, Brailovsky Y, et al. Late right heart failure after left ventricular assist device implantation: contemporary insights and future perspectives. JACC Heart Failure. 2023;11(8 Pt 1):865–878. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical